Clinical trial
Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in…
NCT00197054 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00197054 |
|---|---|
| Title | Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults. |
| Official title | A Phase IIb Randomized, Double-blind, Controlled Study of the Safety, Immunogenicity and Proof-of-concept of RTS,S/AS02A, and RTS,S/AS01B, Two Candidate Malaria Vaccines in Malaria-experienced Adults Living in Western Kenya. |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | GlaxoSmithKline Industry Walter Reed Army Institute of Research (WRAIR) U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum |
| Intervention type | Biological |
| Interventions | RTS, S/AS01B, S/AS02A, Rabipur (Rabies) Vaccine |
| Enrollment | 255 |
| Start date | Jul 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Feb 12, 2021 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: